Health Tech | Founded: 2016 | Burlington, Vermont
Co-Founder, President, & CEO
Sarah Kalil is a med-tech executive with a passion and dedication for leading disruptive technology development from invention to the clinic. Sarah holds a Bachelor of Science in Engineering and a Masters in Pharmaceutical and Medical Device Law. She presently serves as an advisor for Mercy BioAnalytics, Altoida,. and Biocogniv, all emerging technology health tech companies. Sarah is a member of the Dana-Farber Cancer Institute Council and is a Director of the Pleiades Charitable Foundation and the Stowe Land Trust.
Sarah Kalil
Atrial fibrillation (AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. CoreMap has developed an advanced technology diagnostic platform to guide therapy in patients with cardiac arrhythmia. CoreMap’s mission is to improve the lives of people affected by AF. Their technologies will allow for patient-specific treatments, because when treating the 60M patients with AF ‘one size does not fit all’.
Visualizing complex atrial arrhythmias to enable patient-specific treatments
Meet the Co-Founders
Peter Spector
Co-Founder, Inventor, Chief Scientific Officer, and Chairman of the Board of Clinical and Scientific Advisors
Dr. Spector is a cardiac electrophysiologist specializing in atrial fibrillation. For over 25 years, he has balanced clinical care, teaching, and research. He is Director of Cardiac Electrophysiology at the University of Vermont Medical Center and a professor in Medicine and Electrical and Biomedical Engineering. Dr. Spector has authored two books, numerous papers, and is the inventor and founder of VisibleEP and CoreMap, companies focused on advancing cardiac electrophysiology and atrial fibrillation treatment.
You have to “see” AF to treat AF
